Nuveen’s Alder Biopharmaceuticals ALDR Stock Holding History

Nuveen’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-280,066	Closed	-$5.28M	–	3316
2019 Q3	$5.28M	Buy	280,066 +5,635	+2%	+$64.4K	﹤0.01%	1923
2019 Q2	$3.23M	Buy	+274,431	New	+$3.32M	﹤0.01%	2214
2017 Q2	–	Sell	-66,224	Closed	-$1.38M	–	1382
2017 Q1	$1.38M	Buy	66,224 +17,760	+37%	+$393K	0.01%	838
2016 Q4	$1.01M	Buy	48,464 +8,378	+21%	+$218K	0.01%	1148
2016 Q3	$1.31M	Buy	40,086 +7,198	+22%	+$219K	0.01%	981
2016 Q2	$821K	Buy	+32,888	New	+$890K	0.01%	1080

Nuveen's ALDR Position: Q4 2019 in Review

Nuveen sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 280,066 shares — an estimated $5.28M sold.

Nuveen first reported a position in ALDR in Q2 2016 and held it in 6 quarters. The position peaked at $5.28M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Nuveen reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Nuveen sold 280,066 Alder Biopharmaceuticals shares in Q4 2019, an estimated $5.28M.
Nuveen first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 6 quarters.
Nuveen's Alder Biopharmaceuticals position peaked at $5.28M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.